Cargando…

Berberine as a potential agent for breast cancer therapy

Breast cancer (BC) is a common malignancy that mainly occurred in women and it has become the most diagnosed cancer annually since 2020. Berberine (BBR), an alkaloid extracted from the Berberidacea family, has been found with broad pharmacological bioactivities including anti-inflammatory, anti-diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Xiao-Dan, Chen, Li-Juan, Xu, Xin-Yang, Liu, Yan-Jun, Tao, Fan, Zhu, Ming-Hui, Li, Chang-Yun, Zhao, Dan, Yang, Guan-Jun, Chen, Jiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480097/ https://www.ncbi.nlm.nih.gov/pubmed/36119505 http://dx.doi.org/10.3389/fonc.2022.993775

Ejemplares similares

Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy
por: Zhao, Xin, et al.
Publicado: (2022)

The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential
por: Zhu, Ming-Hui, et al.
Publicado: (2023)

Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases
por: Wang, Lulu, et al.
Publicado: (2022)

Berberine-based carbon dots for selective and safe cancer theranostics
por: Zhang, Fan, et al.
Publicado: (2018)

Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
por: Yang, Xiao-Guang, et al.
Publicado: (2019)

Synthesis and In Vitro Photocytotoxicity of 9-/13-Lipophilic Substituted Berberine Derivatives as Potential Anticancer Agents
por: Lin, Hong-Jhih, et al.
Publicado: (2020)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Berberine as a Potential Agent for the Treatment of Colorectal Cancer
por: Jiang, Xi, et al.
Publicado: (2022)

Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer
por: Pan, Yue, et al.
Publicado: (2017)

Antibacterial and Synergy of Berberines with Antibacterial Agents against Clinical Multi-Drug Resistant Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Zuo, Guo-Ying, et al.
Publicado: (2012)

Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m(6)A Methylation
por: Zhao, Ziyi, et al.
Publicado: (2021)

Breast microbiome associations with breast tumor characteristics and neoadjuvant chemotherapy: A case-control study
por: Li, Xuejun, et al.
Publicado: (2022)

Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression
por: Liang, Zhi-Jie, et al.
Publicado: (2021)

Berberine as a Potential Anticancer Agent: A Comprehensive Review
por: Rauf, Abdur, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer
por: Zhong, Xiaoxiao, et al.
Publicado: (2021)

Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo
por: Qian, Ke, et al.
Publicado: (2021)

Multicomponent Therapeutics of Berberine Alkaloids
por: Luo, Jiaoyang, et al.
Publicado: (2013)

Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α
por: Pan, Yue, et al.
Publicado: (2017)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Clinical utility of the pan-immune-inflammation value in breast cancer patients
por: Qi, Xiaoyan, et al.
Publicado: (2023)

Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial
por: Jiao, Dechuang, et al.
Publicado: (2022)

Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
por: Xiong, Ruo-Gu, et al.
Publicado: (2022)

Latissimus dorsi flap – the main force in breast reconstruction for breast tumor in Chinese population
por: Zheng, Shuyue, et al.
Publicado: (2023)

The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis
por: Liu, Hui, et al.
Publicado: (2021)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Protein Glycopatterns in Bronchoalveolar Lavage Fluid as Novel Potential Biomarkers for Diagnosis of Lung Cancer
por: Liu, Lina, et al.
Publicado: (2021)

Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release
por: Tong, Lei, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Pan, Yang-Xun, et al.
Publicado: (2020)

The Disassociation of the A20/HSP90 Complex via Downregulation of HSP90 Restores the Effect of A20 Enhancing the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents
por: Shen, Li-jun, et al.
Publicado: (2021)

Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents
por: Wang, Zhen-hao, et al.
Publicado: (2022)

Effects of CORO2A on Cell Migration and Proliferation and Its Potential Regulatory Network in Breast Cancer
por: Deng, Jun-Li, et al.
Publicado: (2020)

Best treatment options for occult breast cancer: A meta-analysis
por: Wang, Rong, et al.
Publicado: (2023)

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
por: Fan, Jin-Hu, et al.
Publicado: (2023)

Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
por: Li, Yan-Ying, et al.
Publicado: (2023)

Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for berberine therapy of liver cancer
por: Yue, Juan, et al.
Publicado: (2018)

Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer
por: Xin, Xing, et al.
Publicado: (2020)

VWCE Functions as a Tumor Suppressor in Breast Cancer Cells
por: Zhang, Dan, et al.
Publicado: (2020)

Synthesis and Evolution of Berberine Derivatives as a New Class of Antiviral Agents against Enterovirus 71 through the MEK/ERK Pathway and Autophagy
por: Wang, Yan-Xiang, et al.
Publicado: (2018)

Bacteriocins as Potential Anticancer Agents
por: Kaur, Sumanpreet, et al.
Publicado: (2015)

Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study
por: Sang, Yuting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lsege1efo4iceu63uba09ia1p9